References
- Abdullah NA, Wan Mahiyuddin WR, Muhammad NA, et al (2013). Survival rate of breast cancer patients in Malaysia: a population based study. Asian Pac J Cancer Prev, 14, 4591-4. https://doi.org/10.7314/APJCP.2013.14.8.4591
- Alsanabani JA, Gallan W, Saadi AA (2015). Incidence data for breast cancer among Yemeni female patients with palpable breast lumps. Asian Pac J Cancer Prev, 16, 191-4. https://doi.org/10.7314/APJCP.2015.16.1.191
- Band V, Zhao X, Malhotra G, et al (2011).Shared signaling pathways in normal and breast cancer stem cells. J Carcinogenesis, 10, 38. https://doi.org/10.4103/1477-3163.91413
- BhooPathy N, Yip CH, Taib NA, et al (2011). Breast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based breast cancer registry. Breast, 20, 75-80.
- Bray F, JemalA, Grey N, et al (2012). Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncology, 13, 790-801. https://doi.org/10.1016/S1470-2045(12)70211-5
- DeSantis C, Ma J, Bryan L, et al (2014). Breast cancer statistics, 2013. CA-Cancer J Clin, 64, 52-62. https://doi.org/10.3322/caac.21203
- Dey N, Barwick BG, Moreno CS, et al (2013a).Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer, 13, 537. https://doi.org/10.1186/1471-2407-13-537
-
Dey N, Young B, Abramovitz M, et al (2013b). Differential activation of Wnt-
$\beta$ -Catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner. PLoS ONE, 8, 77425. https://doi.org/10.1371/journal.pone.0077425 - FeldmanAL,Eunhee SY (2012). Rosai and ackerman's surgical pathology. JAMA, 307, 201-2.
- Ferrero-Pous M, Trassard M, Le Doussal V, et al (2001). Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients.Appl Immunohisto Mol Morph, 9, 267-75.
- Figueroa JD, Pfeiffer RM, Patel DA, et al (2014). Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst, 106, 286. https://doi.org/10.1093/jnci/dju286
- Hanley KZ (2014). Rosen's Breast Pathology. LWW.
- HussainM,Cunnick GH (2011). Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review. Eur J Surg Oncol, 37, 279-89. https://doi.org/10.1016/j.ejso.2011.01.009
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA-Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kafka A, Basic-KindaS, Pecina-Slaus N (2014). The cellular story of dishevelleds. Croatian Med J, 55, 459-67. https://doi.org/10.3325/cmj.2014.55.459
- Keller PJ, Arendt LM, Skibinski A, et al (2012). Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA, 109, 2772-7. https://doi.org/10.1073/pnas.1017626108
- Lehr HA, Folpe A, Yaziji H, et al (2000). Cytokeratin 8 immunostaining pattern and E-cadherinexpression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol, 114, 190-6. https://doi.org/10.1309/CPUX-KWEH-7B26-YE19
- Majeed W, Aslam B, Javed I, et al (2014). Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev, 15, 3353-8. https://doi.org/10.7314/APJCP.2014.15.8.3353
- Man Y, Izadjoo M, Song G, et al (2011). In situ malignant transformation and progenitor-mediated cell budding: two different pathways for breast ductal and lobular tumor invasion. Cancer, 2, 401-12.
- Moriya T, Kozuka Y, Kanomata N, et al (2009).The role of immunohistochemistry in the differential diagnosis of breast lesions. Pathology, 41, 68-76.
- OmarZA,Tamin NSI (2011). National cancer registry report: malaysia cancer statistics-data and figure 2007. national cancer registry, Ministry of Health Malaysia.
- Quan J, Yahata T, Adachi S, et al (2011). Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Intern J Mol Sci, 12, 971-82. https://doi.org/10.3390/ijms12020971
- Rocha R, Nunes C, Rocha G, et al (2008). Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol Res Pract, 204, 655-62. https://doi.org/10.1016/j.prp.2008.03.010
- Russo J, Lynch H, Russo IH (2001). Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast, 7, 278-91. https://doi.org/10.1046/j.1524-4741.2001.21033.x
- Tiede B, Kang Y (2011). From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res, 21, 245-57. https://doi.org/10.1038/cr.2011.11
- Turashvili G, Bouchal J, Baumforth K, et al (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer, 7, 55. https://doi.org/10.1186/1471-2407-7-55
- Vaurghese AA, Poothiode U, Manjula V (2015). Descriptive study on selected risk factors and histopathology of breast carcinoma in tertiary care centre in Kerala, India with special reference to women uder 40 years old. Asian Pac J Cancer Prev, 16, 181-4. https://doi.org/10.7314/APJCP.2015.16.1.181
- Yeh YC, Wu CC, Wang YK, et al (2011). DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. MolBiol Cell, 22, 940-53.
- Yin HF, Li T, Zhang H, et al (2009). Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast. Chinese J Pathol, 38, 663-7.
- Yoder BJ, Wilkinson EJ, Massoll NA (2007). Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast, 13, 172-9. https://doi.org/10.1111/j.1524-4741.2007.00393.x